Myomo to Report Third Quarter 2018 Results on November 5, 2018
31 October 2018 - 2:20AM
Business Wire
Management to hold a conference call at 4:30
p.m. EST
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a
wearable medical robotics company, today announced that it will
release its financial results for the third quarter 2018 on Monday,
November 5, 2018, after the US markets close.
The Company will host a conference call on Monday, November 5,
2018 at 4:30 p.m. EST featuring remarks by Paul R. Gudonis,
Chairman and Chief Executive Officer, and Ralph A. Goldwasser,
Chief Financial Officer. The conference call, webcast and
accompanying slides can be accessed through Myomo’s Investor
Relations page. Please allow extra time prior to the call to visit
the site and download any necessary software to listen to the live
broadcast.
To dial into the conference call, please dial 1-877-270-2148
from the U.S. or 1-412-902-6510 internationally. A replay of the
conference call will be available approximately one hour after
completion of the live conference call at the Investor Relations
page. A dial-in replay of the call will be available until November
19, 2018; please dial 1-877-344-7529 from the U.S. or
1-412-317-0088 internationally and provide the passcode of
10125914.
About MyomoMyomo, Inc. is a wearable medical robotics
company that offers expanded mobility for those suffering from
neurological disorders and upper limb paralysis. Myomo develops and
markets the MyoPro product line. MyoPro is a powered upper limb
orthosis designed to support the arm and restore function to the
weakened or paralyzed arms of patients suffering from CVA stroke,
brachial plexus injury, traumatic brain or spinal cord injury, ALS
or other neuromuscular disease or injury. It is currently the only
marketed device that, sensing a patient’s own EMG signals through
non-invasive sensors on the arm, can restore an individual’s
ability to perform activities of daily living, including feeding
themselves, carrying objects and doing household tasks. Many are
able to return to work, live independently and reduce their cost of
care. Myomo is headquartered in Cambridge, Massachusetts, with
sales and clinical professionals across the U.S. For more
information, please visit www.myomo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181030005766/en/
For Myomo:ir@myomo.comorInvestor Relations:PCG
AdvisoryVivian Cervantes,
646-863-6244vivian@pcgadvisory.comorPublic Relations:Matter
CommunicationsMeredith Krim, 617-874-5203myomo@matternow.com
Myomo (AMEX:MYO)
Historical Stock Chart
From Apr 2024 to May 2024
Myomo (AMEX:MYO)
Historical Stock Chart
From May 2023 to May 2024